bluebird bio gets CHMP nod for gene therapy ZyntegloA European Medicines Agency advisory panel has recommended a conditional approval for Zynteglo, bluebird bio’s lead gene therapy Share Xbluebird bio gets CHMP nod for gene therapy Zynteglohttps://pharmaphorum.com/news/bluebird-bio-gets-chmp-nod-for-gene-therapy-zynteglo/
